Document Detail


Expression of glycoproteins bearing complex human-like glycans with galactose terminal in Hansenula polymorpha.
MedLine Citation:
PMID:  23136055     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Glycoproteins derived from Hansenula polymorpha can not be used for therapeutic purposes due to their high-mannose type asparagine-linked (N-linked) glycans, which result in immune reactions and poor pharmacokinetic behaviors in human body. Previously, we reported that the trimannosyl core N-linked glycans (Man(3)GlcNAc(2)) intermediate can be generated in endoplasmic reticulum in HpALG3 and HpALG11 double-mutant H. polymorpha. Here, we describe the further modification of the glycosylation pathway in this double-defect strain to express glycoproteins with complex human-like glycans. After eliminating the impact of HpOCH1, three glycosyltransferases were introduced into this triple-mutant strain. When human β-1,2-N-acetylglucosaminyltransferase I (hGnTI) was efficiently targeted in early Golgi, more than 95 % glycans attached to the glycoproteins were added one N-acetylglucosamine (GlcNAc). With subsequently introduction of rat β-1,2-N-acetylglucosaminyltransferase II (rGnTII) and human β-1,4-galactosyltransferase I (hGalTI), several glycoengineered strains can produce glycoproteins bearing glycans with terminal N-acetylglucosamine or galactose. The expression of glycoproteins with glycan Gal(2)GlcNAc(2)Man(3)GlcNAc(2) represents a significant step toward the ability to express fully humanized glycoproteins in H. polymorpha. Furthermore, several shake-flask and bioreactor fermentation experiments indicated that, although the cells do display a reduction in growth rate, the glycoengineered strains are still suitable for high-density fermentation.
Authors:
Hui Wang; Hao-Lei Song; Qian Wang; Bing-Sheng Qiu
Related Documents :
24836065 - Design, synthesis and biological evaluation of novel isoniazid derivatives with potent ...
24177795 - Isolation of a selective marker from cephalosporium acremonium by complementation of an...
23552365 - Genome-scale analyses of butanol tolerance in saccharomyces cerevisiae reveal an essent...
17451445 - Mesorhizobium spp. are the main microsymbionts of caragana spp. grown in liaoning provi...
19948865 - Fates of acid-resistant and non-acid-resistant shiga toxin-producing escherichia coli s...
8104975 - Pulsed-field gel electrophoresis for differentiation of hospital isolates of klebsiella...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-8
Journal Detail:
Title:  World journal of microbiology & biotechnology     Volume:  -     ISSN:  1573-0972     ISO Abbreviation:  World J. Microbiol. Biotechnol.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9012472     Medline TA:  World J Microbiol Biotechnol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Institute of Microbiology, Chinese Academy of Sciences, No. 1 Beichen West Road, Chaoyang District, Beijing, 100101, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In vitro potency and efficacy favor later generation fluoroquinolones for treatment of canine and fe...
Next Document:  Interactions between chemical and climate stressors: A role for mechanistic toxicology in assessing ...